Summit Securities Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.9K | Buy |
+395
| New | +$30.9K | 0.01% | 509 |
|
|
2025
Q1 | – | Sell |
-320
| Closed | -$23.7K | – | 732 |
|
|
2024
Q4 | $23.7K | Buy |
+320
| New | +$23.7K | ﹤0.01% | 247 |
|
|
2024
Q2 | – | Sell |
-2
| Closed | – | – | 504 |
|
|
2024
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 440 |
|
|
2023
Q3 | – | Sell |
-793
| Closed | -$75K | – | 549 |
|
|
2023
Q2 | $75K | Sell |
793
-419
| -35% | -$39.6K | 0.01% | 223 |
|
|
2023
Q1 | $100K | Sell |
1,212
-3,443
| -74% | -$284K | 0.01% | 179 |
|
|
2022
Q4 | $347K | Buy |
4,655
+3,244
| +230% | +$242K | 0.01% | 155 |
|
|
2022
Q3 | $117K | Buy |
1,411
+112
| +9% | +$9.29K | 0.01% | 337 |
|
|
2022
Q2 | $124K | Buy |
1,299
+1,043
| +407% | +$99.6K | 0.02% | 239 |
|
|
2022
Q1 | $30K | Buy |
+256
| New | +$30K | ﹤0.01% | 443 |
|